Background
Inflammatory disorders of the breast (IDB) could be categorized into lactational mastitis (LM) and non-lactational mastitis (NLM) according to the time of occurrence [
1]. The reported incidence has shown the IDB ranges from 3 to 33% of women in lactation period, and less than 10% in non-lactating ones [
2,
3]. Whether LM or NLM, to resist distinct clinical manifestations of localized and associated systemic symptoms, women commonly adopt antibiotic therapy [
4,
5]. Delayed treatment may cause severe outcomes such as sepsis for LM and breast fistula for NLM. Breast abscess is also a potential complication for IDB [
6]. Due to the long treatment duration, ineffective adopting antibiotic and easy recurrence, the treatment of NLM faces tremendous challenge [
7,
8], which may result in considerable economic burden and psychological distress in women. In addition, breastfeeding is utmost important and is considered as the origin of life. The beginning and development of LM may cause premature cessation of breastfeeding, suffering to both mothers and children [
9]. Despite routine treatment including antibiotic has been used extensively, the effectiveness and security of antibiotic therapy has not been confirmed yet [
8,
10,
11]. Thus, it is crucial to clarify the etiology of IDB and to prevent the occurrence of IDB from its root causes. However, tangible etiology concerning IDB remains unclear due to research deficiency [
12,
13]. Therefore, considering the benefits of health and current treatments are not all effective, it is imperative to seek the etiology of IDB.
The GM, familiar with the "second genome of the human", is tightly linked to our benefits and disorders [
14]. Due to the presence of gut–mammary gland axis, gut dysbiosis may contribute to the occurrence and development of breast disorders [
15,
16]. Animal studies have proven disturbance of GM and related metabolites induced the development of IDB in mice [
17], and feces microbiota transplantation (FMT) could reverse adverse effects [
18]. Microbiota-depleted mice developed IDB symptoms when were transplanted with the GM from unhealthy cows with IDB [
19]. Nevertheless, the evidence of randomized controlled trials (RCTs) between IDB and GM is scanty and has not been fully evaluated [
20]. In addition, observational studies of GM and IDB are vulnerable to external factors such as genotyping of gut microbial community, dietary appetite, mood and life mode [
21,
22]. It is unknown whether the specific taxa of GM cause IDB or not. Therefore, it is urgent to confirm causality of GM on IDB and to understand which microbiota taxa developing IDB.
Due to limitations of medical ethics and high costs, some RCTs are difficult to carry out in practical work [
23]. MR study was introduced to exploit in the inference of epidemiological causes. Based on Mendel's Laws of Inheritance, MR could progress causal inference among exposure and outcome [
24]. Mounting MR analysis has been introduced to confirm the causality between GM and disorders, by way of example, cancers [
25], cardiovascular diseases [
26] and depressive disorder [
27]. In this study, MiBioGen and FinnGen consortiums, two large GWAS databases, were employed for statistical analysis. A two-sample MR design was conducted to verify causality and to provide a theoretical foundation for the etiology and biomarker of IDB.
Discussion
As far as we know, our study takes the lead in assessing the causality between GM and IDB in terms of the genetic level. In this study, two-sample MR analysis based on the largest GWAS data set gave fairly strong evidence that gut microbiome plays non-negligible role in the occurrence and progression of IDB, in which, metabolites may be involved in. Results displayed that Eubacterium rectale group, Olsenella and Ruminiclostridium-6 had an anti-protective effect on IDB, whereas Peptococcus had a protective effect on IDB.
Several studies have reported the association between
Ruminiclostridium-6 and other disorders, although the relationship between
Ruminiclostridium-6 and IDB has not been explored. Previous studies revealed that
Ruminiclostridium-6 acted as a vital regulatory effect in colitis.
Ruminiclostridium-6 could contribute to the release of proinflammatory factors such as IL-6, IL-1β, TNF-α and IL-8 and deteriorate colitis [
54]. In addition, a cohort study has shown the
Ruminiclostridium-6 was significantly enriched in community-acquired pneumonia patients, implying its potential pathogenicity [
55]. IDB is an infection of mammary gland [
56] that may be due to a severe disruption of the blood–milk barrier [
57] caused by harmful factors (e.g., enteropathogenic bacteria), which in turn is transferred from the intestine to the breast. Current evidence focuses on the pathogenesis of rumen-induced IDB. Rumen-derived LPS decreased the expression of tight junctional proteins, in turn disrupts the blood–milk barrier and increasing permeability. Therefore, we hypothesized that
Ruminiclostridium-6 may have a performance impact on IDB via regulating proinflammatory factors to disrupt the blood–milk barrier and deteriorate IDB.
Conclusive evidence also needed to confirm how
Eubacterium rectale group and
Olsenella increase the risk of IDB. Although
Eubacterium rectale group as one of butyrate-producing flora benefits to certain disorder [
58], butyrate is also reported to promote tumorigenesis [
59]. The evidence against
Eubacterium rectale group have been documented. Islam et al has found
Eubacterium rectale group inhibited CD83 to keep mice in systemic inflammation [
60]. Wang et al. also revealed the
Eubacterium rectale group played proinflammatory role in colorectal cancer [
61]. Therefore, we could infer a conclusion that
Eubacterium rectale group exacerbates IDB through systemic inflammation. For
Olsenella, only observational study has reported its changes with disease [
62,
63]. Our study verified the potential harmfulness of
Olsenella in humans at the first time and
Olsenella has the potential to be a candidate of biomarker of IDB.
Trillions of symbiotic GM on the surface of the human gastrointestinal mucosa maintain the host health. As the degree of IDB increased, short chain fatty acids (SCFAs) were significantly decreased [
64]. A strategy of probiotics treatment may reduce the risk [
65].
Peptococcus has a solid positive correlation with valeric acid and butyrate [
66‐
68]. Probiotics and SCFAs may inhibit inflammation and maintain blood–milk barrier function. Research revealed SCFAs participated in the energy supply of tight junction proteins [
69], suggesting its function in the developing of blood–milk barrier. Propionate acid shielded lactating women from IDB by modulating the blood–milk barrier [
70]. The research also pointed that butyrate, one of SCFAs, was at dominance of modulating the inflammatory response [
18,
71]. Moreover, butyrate repairs blood–milk barrier by improving tight junction proteins [
72]. Although few reports concentrated on
Peptococcus acting as a probiotic in the past, our study has found
Peptococcus may become a candidate of probiotics therapy today. Nevertheless, more RCTs are needed to conduct to support the novel treatment.
This research has several advantages. Genetic variation is not affected by confounding factors. Thus, the measurement error between genetic variation and its effects is relatively small. Based on this, we employed MR analysis to determine the causal effect between GM and IDB. Genetic data were adopted from the latest large GWAS, keeping the robustness of IVs in the MR analysis. Several statistical techniques were performed to detect the precision of results. A two-sample MR design widely used because it avoids bias by nonoverlapping data.
However, several limitations in this study deserve noting. Firstly, weak instrumental bias may not be avoided even if satisfying the MR assumptions (IVs are closely correlated with GM taxa). Secondly, the GWAS recruited subjects only of particular race or nationality, the generalization of findings in our research could not be suitable. MR studies of cross racial may consider for better generalizability. Thirdly, MR analysis typically reveals a lifetime exposure, the existence of canalization may cause overestimation of effect size. Further RCTs should be performed to exam the effect. Fourthly, we conducted MR analysis on five species level, however, we only found eligible SNPs on genus level, thus we could try our best to enlarge the sample size to improve the effectiveness of samples. Finally, the research of biological mechanisms should be paid attention to interpret MR results.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.